2Halliwell RF, Davery PG, Lambert JJ. Antagonism of GABA receptor by 4-quinolones[J]. J Antimicrob Chemother, 1993, 31: 457. 被引量：1
3Domagala JM. Structure-activity and structure-side-effect relationships for quinolone antibacterials [J]. J Antimicroh Chemother, 1994, 23: 685. 被引量：1
4William PD, Helton DR. The proconvulsive activity of quinolone antibiotics in an animal model [J]. Toxicol Lett, 1991, 58: 21. 被引量：1
5Schmuck G, Schurmann A, Schluter G, et al. Determination of the excitatory potencyes of different fluoroquinolones in the central nervous system by an in vitro model[J]. Antimicrob Agents Chemother, 1998, 42 :1831. 被引量：1
6Hod S, Shimida J, Sato A, et al. Comparison of the inhibitory effects of new quinolone on gamma-aminobu-tyric acid receptor binding in the presence of anti-inflammatory drugs[J]. Rev Infect Dis, 1989, ( Suppl 5 ) :S1397. 被引量：1
7Robinstein E, Camm J. Cardiotoxicity of fluoroquinolones[J]. J Antimicrob Chemother, 2002,49: 593. 被引量：1
8Hagiwara T, Satch S, Kasai Y, et al. A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia[J]. Jpn J Pharmacol, 2001,87: 231. 被引量：1
9Anderson ME, Mazur A, Yang T, et al, Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotic [J]. J Pharmacol Exp Ther, 2001, 296: 806. 被引量：1
10Kang J, Wang L, Chen XL, et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K^+ Channel HERG[J]. Mol Pharmacol, 2001,59: 122. 被引量：1
